Bioneer Corp
064550.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$899.49B
Close$
$-23960.22
168.8% downside
Current Fair Value
168.8% downsideOvervalued by 168.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $899.49 Billion |
|---|---|
| Enterprise Value | $943.12 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-797.92 |
| Beta | -0.35 |
| Outstanding Shares | 25,797,000 |
Return
| Return on Equity | -8.39% |
|---|---|
| Return on Assets | -4.78% |
| Return on Invested Capital | 36.20% |
Valuation & Multiples
| P/E Ratio | -10.91 |
|---|---|
| PEG | 17.17 |
| Price to Sales | 3.01 |
| Price to Book Ratio | 3.91 |
| Enterprise Value to Revenue | 3.16 |
| Enterprise Value to EBIT | 8.53 |
| Enterprise Value to Net Income | -53 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bioneer Corporation
608 employees
CEO: Han-Oh Park Bioneer Corporation, established in 1992 and headquartered in Daejeon, South Korea, is a biotechnology company involved in diverse fields such as research products, molecular diagnostics, pharmaceuticals, and probiotics. For the biotechn...